118 related articles for article (PubMed ID: 1317275)
21. Differential effects of procainamide, lidocaine and acetylstrophanthidin on body surface potentials and epicardial conduction in dogs with chronic myocardial infarction.
de Langen CD; Hanich RF; Michelson EL; Kadish AH; Levine JH; Balke CW; Spear JF; Moore EN
J Am Coll Cardiol; 1988 Feb; 11(2):403-13. PubMed ID: 3339181
[TBL] [Abstract][Full Text] [Related]
22. Modulation of procainamide's effect on conduction by cellular uncoupling in perfused rabbit hearts.
Spear JF; Hook BG; Josephson ME; Moore EN
J Cardiovasc Electrophysiol; 1997 Feb; 8(2):199-214. PubMed ID: 9048250
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological effects of high cocaine concentrations on intact canine heart. Evidence for modulation by both heart rate and autonomic nervous system.
Clarkson CW; Chang C; Stolfi A; George WJ; Yamasaki S; Pickoff AS
Circulation; 1993 Mar; 87(3):950-62. PubMed ID: 8443914
[TBL] [Abstract][Full Text] [Related]
24. Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization.
Mörtl D; Agneter E; Krivanek P; Koppatz K; Todt H
J Cardiovasc Pharmacol; 2003 Jun; 41(6):870-9. PubMed ID: 12775964
[TBL] [Abstract][Full Text] [Related]
25. Prolongation of the conduction time of early premature beats: a marker of ventricular action potential duration.
Avitall B; Naimi S; Levine HJ
Am Heart J; 1988 Nov; 116(5 Pt 1):1247-52. PubMed ID: 2461067
[TBL] [Abstract][Full Text] [Related]
26. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit.
Stambler BS; Wood MA; Ellenbogen KA
J Am Coll Cardiol; 1996 Feb; 27(2):453-61. PubMed ID: 8557920
[TBL] [Abstract][Full Text] [Related]
27. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
Derakhchan K; Pagé P; Lambert C; Kus T
J Pharmacol Exp Ther; 1994 Jul; 270(1):47-54. PubMed ID: 8035342
[TBL] [Abstract][Full Text] [Related]
28. Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heart.
Bajaj AK; Kopelman HA; Wikswo JP; Cassidy F; Woosley RL; Roden DM
Circulation; 1987 May; 75(5):1065-73. PubMed ID: 2436827
[TBL] [Abstract][Full Text] [Related]
29. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
30. Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
Inoue H; Zipes DP
Circulation; 1987 Sep; 76(3):637-47. PubMed ID: 3621524
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
32. Facilitation of localized conduction block with procainamide during entrainment of sustained ventricular tachycardia.
Okumura K; Honda T; Nishigami K; Hayasaki K
Am Heart J; 1989 Sep; 118(3):630-2. PubMed ID: 2773782
[No Abstract] [Full Text] [Related]
33. Effects of procainamide on wave-front dynamics during ventricular fibrillation in open-chest dogs.
Kwan YY; Fan W; Hough D; Lee JJ; Fishbein MC; Karagueuzian HS; Chen PS
Circulation; 1998 May; 97(18):1828-36. PubMed ID: 9603538
[TBL] [Abstract][Full Text] [Related]
34. Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue.
Toy W; Sasyniuk BI
J Pharmacol Exp Ther; 1990 Aug; 254(2):603-11. PubMed ID: 2166798
[TBL] [Abstract][Full Text] [Related]
35. Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs.
Ranger S; Nattel S
Circulation; 1995 Sep; 92(5):1300-11. PubMed ID: 7648679
[TBL] [Abstract][Full Text] [Related]
36. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.
Brachmann J; Scherlag BJ; Rosenshtraukh LV; Lazzara R
Circulation; 1983 Oct; 68(4):846-56. PubMed ID: 6616779
[TBL] [Abstract][Full Text] [Related]
37. Rate-dependent effects of procainamide on His-Purkinje conduction in man.
Gang ES; Denton TA; Oseran DS; Mandel WJ; Peter T
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1525-9. PubMed ID: 4003294
[TBL] [Abstract][Full Text] [Related]
38. Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments.
Starmer CF; Lastra AA; Nesterenko VV; Grant AO
Circulation; 1991 Sep; 84(3):1364-77. PubMed ID: 1653123
[TBL] [Abstract][Full Text] [Related]
39. Procainamide and retrograde atrioventricular nodal conduction in man.
Shenasa M; Gilbert CJ; Schmidt DH; Akhtar M
Circulation; 1982 Feb; 65(2):355-62. PubMed ID: 7053895
[TBL] [Abstract][Full Text] [Related]
40. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
